Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
705,983,417
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
1,896,857
-
Shares change
-
+1,896,857
-
Total reported value, excl. options
-
$2,963,000
-
Value change
-
+$2,963,000
-
Number of buys
-
2
-
Price
-
$8.42
Significant Holders of Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR) as of Q4 2020
2 filings reported holding PHAR - Pharming Group N.V. - Ordinary Shares / American Depositary Shares as of Q4 2020.
Pharming Group N.V. - Ordinary Shares / American Depositary Shares (PHAR) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,896,857 shares
of 705,983,417 outstanding shares and own 0.27% of the company stock.
Largest 2 shareholders include JW Asset Management, LLC (1,895,941 shares) and UBS Group AG (916 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.